Kazia Therapeutics Stock Forecast

KZIA's stock price has decreased by -53.6% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Kazia Therapeutics stock have an average target of 11.5, with a low estimate of 3.00 and a high estimate of 20. The average target predicts an increase of 1,097.92% from the current stock price of 0.96.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$3.00	$11.5	$20	$20
Change	+212.50%	+1097.9%	+1983.3%	+1983.3%

* Price targets were last updated on Feb 6, 2025.

Analyst Ratings

The average analyst rating for Kazia Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	1	1	1	1	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Initiates $3	Strong Buy	Initiates	$3	+212.50%	Feb 6, 2025
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+1,983.33%	Jul 12, 2024
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades $20	Hold → Strong Buy	Upgrades	$20	+1,983.33%	Apr 11, 2023
Jason McCarthy Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Aug 2, 2022
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Aug 2, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 2.48M

Revenue Next Year

n/a

EPS This Year

-5.30

from -10.16

EPS Next Year

-2.59

from -5.30

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2020	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	988.11K	15.18M	10.00K	1,000.00	2.48M	-	-	-
Revenue Growth	-31.38%	1,436.54%	-99.93%	-90.00%	248,000.00%	-	-	-
EPS	-17.07	-7.16	-18.88	-11.11	-10.16	-5.30	-2.59	-2.01
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3	3

Financial currency is AUD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-5.46	-2.67	-2.07
Avg	-5.30	-2.59	-2.01
Low	-5.10	-2.49	-1.93

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.